What is Protosthetics?
Protosthetics operates at the intersection of healthcare technology and advanced manufacturing, focusing on the orthotics and prosthetics (O&P) sector. Their core offering, the Galileo system, represents a paradigm shift from traditional O&P fabrication methods. By integrating digital scanning, CAD modeling, and 3D printing capabilities into a single clinic-based workflow, Protosthetics empowers O&P professionals to deliver customized devices more rapidly and cost-effectively. The company's commitment to ongoing research and development ensures that their technology remains at the forefront of the industry, addressing the evolving needs of both clinicians and patients.
How much funding has Protosthetics raised?
Protosthetics has raised a total of $1.3M across 1 funding round:
Private Equity
$1.3M
Private Equity (2016): $1.3M, investors not publicly disclosed
What's next for Protosthetics?
With the recent major strategic investment, Protosthetics is poised for accelerated growth and further innovation. The capital infusion is expected to fuel advancements in their proprietary 3D printing technology and expand the capabilities of the Galileo platform. Strategic expansion into new markets and strengthening partnerships within the healthcare ecosystem are likely next steps. This backing will also support enhanced customer support and training initiatives, ensuring widespread adoption and optimal utilization of their solutions, ultimately aiming to set new standards in patient care and clinical efficiency within the orthotics and prosthetics field.
See full Protosthetics company page
